FeaturesSignalPricingFounders
Log inGet started free
FC

Foresite Capital

Private EquityActive

Foresite Capital provides catalytic capital to transformative healthcare companies at all stages.

San Francisco, United StatesFounded 2004foresitecapital.com/
87
Investments
37
Exits
$1.6B
AUM
42.5%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Foresite Capital.

Get started free

Investment Thesis & Strategy

Foresite Capital invests in transformative healthcare companies across various stages, leveraging its expertise in fintech and venture capital to drive innovation in the healthcare sector.

Investment Activity

Deals per year over the last 6 years

2
2016
1
2017
3
2018
4
2019
0
2020
2
2021

Portfolio Companies

Selected investments from their portfolio of 87 companies

E
Eikon Therapeutics
Biotech · Series B, 2021
Active
G
Generate Biomedicines
Biotech · Series B, 2021
Active
S
Sana Biotechnology
Biotech · Series A, 2019
Active
L
Lyra Therapeutics
Biotech · Series C+, 2019
Active
V
Verve Therapeutics
Biotech · Series A, 2019
Active
I
Insitro
Biotech · Series B, 2019
Active
C
Cerevel Therapeutics
Biotech · Series A, 2018
Active
E
Element Biosciences
Biotech · Series C+, 2018
Active
R
Recursion Pharmaceuticals
Biotech · Series B, 2018
Active
T
Tempus
Healthcare · Series C+, 2017
Active
F
Freenome
Biotech · Series B, 2016
Active
G
GRAIL
Biotech · Series B, 2016
Active

Frequently Asked Questions

Foresite Capital focuses on Series B, Series C+ stage investments.

Related Investors

Spectrum Equity

San Francisco, United States · 107 deals

Burrill & Company

San Francisco, United States · 87 deals

FTV Capital

San Francisco, United States · 78 deals

Francisco Partners

San Francisco, United States · 49 deals

venBio Partners

San Francisco, United States · 48 deals

Serent Capital

San Francisco, United States · 36 deals